Skip to main content

Israel in talks for Pfizer's vaccine, official says

US drug company Pfizer said on Monday that its COVID-19 vaccine is more than 90% effective.
GettyImages-1229555002.jpg

The Israeli government is in talks to acquire the Pfizer-produced coronavirus vaccine, which the American drugmaker said Monday is more than 90% effective in preventing COVID-19.

Pfizer, which developed its experimental vaccine with German partner BioNTech, announced on Monday promising findings following phase 3 of the clinical trial. An initial analysis indicated an efficacy rate of more than 90% among participants without evidence of a prior COVID-19 infection.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.